Palevsky P M, Bhagrath R, Greenberg A
Renal-Electrolyte Division, University of Pittsburgh School of Medicine, PA 15261, USA.
Ann Intern Med. 1996 Jan 15;124(2):197-203. doi: 10.7326/0003-4819-124-2-199601150-00002.
To determine the incidence, clinical characteristics, and outcome for general medical-surgical hospital patients with hypernatremia.
A prospective cohort study.
A 942-bed urban university hospital.
All patients who developed a serum sodium concentration of 150 mmol/L or greater during a 3-month observation period.
Daily fluid balance, mental status, and serum and urine electrolytes and osmolality.
103 patients were identified. Eighteen patients were hypernatremic on hospital admission, and 85 developed hypernatremia during hospitalization. Patients who developed hypernatremia during hospitalization were younger than patients who developed hypernatremia before hospital admission (mean age +/- SD, 58.9 +/- 19.2 years compared with 76.6 +/- 16.6 years; P < 0.01) but did not differ in age from the patients of the general hospitalized population. Eighty-nine percent of patients who developed hypernatremia during hospitalization had urine concentrating defects, primarily as the result of the use of diuretics or of solute diuresis, whereas only 50% of patients who were hypernatremic on admission could be shown to have concentrating defects (P < 0.01). Fifty-five percent of all hypernatremic patients had increased insensible water losses, and 35% had increased enteral water losses. Eighty-six percent of patients with hospital-acquired hypernatremia lacked free access to water, 74% had enteral water intake of less than 1 L/d, and 94% received less than 1 L of intravenous electrolyte-free water per day during the development of hypernatremia. No supplemental electrolyte-free water was prescribed during the first 24 hours of hypernatremia in 49% of patients. The duration of hypernatremia was shorter in patients who were hypernatremic on admission (median duration, 3 days) than in patients with hospital-acquired hypernatremia (median duration, 5 days; P < 0.05). Mortality was 41% for all patients, but hypernatremia was judged to have contributed to mortality in only 16% of patients.
Although the development of hypernatremia before hospital admission occurs primarily in geriatric patients, hospital-acquired hypernatremia was more common in our cohort and had an age distribution similar to that of the general hospitalized population. Hospital-acquired hypernatremia was primarily iatrogenic, resulting from inadequate and inappropriate prescription of fluids to patients with predictably increased water losses and impaired thirst or restricted free water intake or both. Treatment of hypernatremia is often inadequate or delayed. Efforts to manage hypernatremia better and altogether avoid hospital-acquired hypernatremia should focus on both physician education and the development of hospital systems to prevent errors in fluid prescription.
确定综合内科-外科医院高钠血症患者的发病率、临床特征及转归。
前瞻性队列研究。
一所拥有942张床位的城市大学医院。
在3个月观察期内血清钠浓度达到或超过150 mmol/L的所有患者。
每日液体平衡、精神状态以及血清和尿液电解质及渗透压。
共识别出103例患者。18例患者入院时即存在高钠血症,85例在住院期间发生高钠血症。住院期间发生高钠血症的患者比入院前发生高钠血症的患者年轻(平均年龄±标准差,分别为58.9±19.2岁和76.6±16.6岁;P<0.01),但与普通住院患者的年龄无差异。住院期间发生高钠血症的患者中89%存在尿液浓缩功能缺陷,主要是由于使用利尿剂或溶质利尿所致,而入院时即存在高钠血症的患者中只有50%可显示有浓缩功能缺陷(P<0.01)。所有高钠血症患者中55%存在不显性失水量增加,35%存在肠道失水量增加。医院获得性高钠血症患者中86%无法自由获取水分,74%的肠道水分摄入量少于1 L/d,94%在高钠血症发生期间每日静脉输注的无电解质水分少于1 L。49%的患者在高钠血症发生的最初24小时内未开具补充无电解质水分的医嘱。入院时即存在高钠血症的患者高钠血症持续时间较短(中位持续时间为3天),短于医院获得性高钠血症患者(中位持续时间为5天;P<0.05)。所有患者的死亡率为41%,但仅16%的患者被判定高钠血症导致了死亡。
虽然入院前发生高钠血症主要见于老年患者,但在我们的队列中,医院获得性高钠血症更为常见,其年龄分布与普通住院患者相似。医院获得性高钠血症主要是医源性的,是由于对可预见的失水量增加且口渴受损或自由水摄入受限或两者皆有的患者液体处方不足和不当所致。高钠血症的治疗往往不足或延迟。更好地管理高钠血症并完全避免医院获得性高钠血症的努力应侧重于医生教育以及建立医院系统以防止液体处方错误。